Biomedical Engineering Reference
In-Depth Information
33. Kim, K., Lee, M., Park, H., Kim, J.H., Kim, S., et al., 2006, “Cell-permeable
and biocompatible polymeric nanoparticles for apoptosis imaging,” J. Am.
Chem. Soc., 128, pp. 3490-3491.
34. Nasongkla, N., Bey, E., Ren, J., Ai, H., Khemtong, C., et al., 2006,
“Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive
drug delivery systems,” Nano Lett., 6, pp. 2427-2430.
35. Moghimi, S.M., Hunter, A.C., Murray, J.C., 2001, “Long-circulating and
target-specific nanoparticles: theory to practice,” Pharmacol. Rev., 53,
pp. 283-318.
36. Moghimi, S. M., and Szebeni, J., 2003, “Stealth liposomes and long circulating
nanoparticles: critical issues in pharmacokinetics, opsonization and protein-
binding properties,” Prog. Lipid Res., 42, pp. 463-478.
37. Oh, P., Li, Y., Yu, J., Durr, E., Krasinka, K.M., et al., 2004, “Subtractive
proteomic mapping of the endothelial surface in lung and solid tumours for
tissue-specific therapy,” Nature, 429, pp. 629-635.
38. Panyam, J., and Labhasetwar, V., 2004, “Biodegradable nanoparticles for
drug and gene delivery to cells and tissues,” Adv. Drug Deliv. Rev., 55,
pp. 329-347.
39. Veerareddy, P.R., and Vobalabonia, V., 2004, “Lipid-based formulas of
amphotericin B,” Drugs Today, 40, pp. 133-145.
40. Agrawal, A.K., and Gupta, C.M., 2000, “ Tuftsin-bearing liposomes in
treatment of macrophage-based infections,” Adv. Drug Deliv. Rev., 41,
pp. 135-146.
41. Dileo, J., Banerjee, R., Whitmore, M., Nayak, J., Falo, L., Huang, L., 2003,
“LPD mediated antigen delivery to antigen presenting cells results in enhanced
anti-tumor immune responses,” Mol. Ther., 7, pp. 640-648.
42. Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M.C.,
Steinman, R.M., 2002, “Efficient targeting of protein antigen to the dendritic
cell receptor DEC-205 in the steady state leads to antigen presentation on
major histocompatibility complex class I products and peripheral CD8+ T cell
tolerance,” J. Exp. Med., 196, pp. 1627-1638.
43. Bhojani, M.S., Van Dort, M., Rehemtulla, A., Ross, B.D., 2010, “ Targeted
imaging and therapy of brain cancer using theranostic nanoparticles,” Mol.
Pharm., 7, pp. 1921-1929.
44. Reddy, G.R., Bhojani, M.S., McConville, P., Moody, J., Moffat, B.A., et al.,
2006, “Vascular targeted Nanoparticles for imaging and treatment of brain
tumors,” Clin. Cancer Res., 12, pp. 6677-6686.
45. Porkka, K., Laakkonen, P., Hoffman, J.A., Bernasconi, M., Ruoslathi, E., 2002,
“A fragment of the HMGN2 protein homes to the nuclei of tumor cells and
tumor endothelial cells
in vivo
,” Proc. Natl. Acad. Sci. U.S.A., 99, pp. 7444-
7449.
46. Christian, S., Pilch, J., Akerman, M.E., Porkka, K., Laakkonen, P., Ruoslahti,
E., 2003, “Nucleolin expressed at the cell surface is a marker of endothelial cells
in angiogenic blood vessels,” J. Cell. Biol., 163, pp. 871-878.
47. Sun, C., Veiseh, O., Gunn, J., Fang, C., Hansen, S., et al., 2008, “
In vivo
MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic
nanoprobes,” Small, 4, pp. 372-379.
